133 related articles for article (PubMed ID: 9756130)
21. Anti-interleukin 6 receptor antibodies attenuate antibody recall responses in a mouse model of allosensitization.
Kim I; Wu G; Chai NN; Klein AS; Jordan S
Transplantation; 2014 Dec; 98(12):1262-70. PubMed ID: 25286051
[TBL] [Abstract][Full Text] [Related]
22. Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys.
Mihara M; Kotoh M; Nishimoto N; Oda Y; Kumagai E; Takagi N; Tsunemi K; Ohsugi Y; Kishimoto T; Yoshizaki K; Takeda Y
Clin Immunol; 2001 Mar; 98(3):319-26. PubMed ID: 11237555
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the mechanism of action of anti-human interleukin-6 and anti-human interleukin-6 receptor-neutralising monoclonal antibodies.
Kalai M; Montero-Julian FA; Brakenhoff JP; Fontaine V; De Wit L; Wollmer A; Brailly H; Content J; Grötzinger J
Eur J Biochem; 1997 Nov; 249(3):690-700. PubMed ID: 9395315
[TBL] [Abstract][Full Text] [Related]
24. Immunization against an IL-6 peptide induces anti-IL-6 antibodies and modulates the Delayed-Type Hypersensitivity reaction in cynomolgus monkeys.
Desallais L; Bouchez C; Mouhsine H; Moreau G; Ratsimandresy R; Montes M; Do H; Quintin-Colonna F; Zagury JF
Sci Rep; 2016 Jan; 6():19549. PubMed ID: 26782790
[TBL] [Abstract][Full Text] [Related]
25. Anti-IL-6 receptor antibody increases blood IL-6 level via the blockade of IL-6 clearance, but not via the induction of IL-6 production.
Uchiyama Y; Yoshida H; Koike N; Hayakawa N; Sugita A; Nishimura T; Mihara M
Int Immunopharmacol; 2008 Nov; 8(11):1595-601. PubMed ID: 18664393
[TBL] [Abstract][Full Text] [Related]
26. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.
Hashizume M; Hayakawa N; Mihara M
Rheumatology (Oxford); 2008 Nov; 47(11):1635-40. PubMed ID: 18786965
[TBL] [Abstract][Full Text] [Related]
27. [A humanized anti-IL-6 receptor antibody(MRA) in RA therapy].
Hagihara K; Nishimoto N; Yoshizaki K
Nihon Rinsho; 2002 Dec; 60(12):2401-7. PubMed ID: 12510369
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric detection of receptors for interleukin-6 on bone marrow and peripheral blood cells of humans and rhesus monkeys.
Wognum AW; van Gils FC; Wagemaker G
Blood; 1993 Apr; 81(8):2036-43. PubMed ID: 8097119
[TBL] [Abstract][Full Text] [Related]
29. Characterization of lymphocyte subpopulations in the blood of the cynomolgus monkey using flow cytometry.
Sagara N; Furuhama K; Onodera T
J Appl Toxicol; 1990 Jun; 10(3):211-5. PubMed ID: 2116470
[TBL] [Abstract][Full Text] [Related]
30. Characterization of murine anti-human Fab antibodies for use in an immunoassay for generic quantification of human Fab fragments in non-human serum samples including cynomolgus monkey samples.
Stubenrauch K; Wessels U; Essig U; Kowalewsky F; Vogel R; Heinrich J
J Pharm Biomed Anal; 2013 Jan; 72():208-15. PubMed ID: 23017233
[TBL] [Abstract][Full Text] [Related]
31. The Vgamma2/Vdelta2 T-cell repertoire in Macaca fascicularis: functional responses to phosphoantigen stimulation by the Vgamma2/Jgamma1.2 subset.
Cairo C; Propp N; Hebbeler AM; Colizzi V; Pauza CD
Immunology; 2005 Jun; 115(2):197-205. PubMed ID: 15885125
[TBL] [Abstract][Full Text] [Related]
32. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.
Hart TK; Cook RM; Zia-Amirhosseini P; Minthorn E; Sellers TS; Maleeff BE; Eustis S; Schwartz LW; Tsui P; Appelbaum ER; Martin EC; Bugelski PJ; Herzyk DJ
J Allergy Clin Immunol; 2001 Aug; 108(2):250-7. PubMed ID: 11496242
[TBL] [Abstract][Full Text] [Related]
33. Cynomolgus monkey model of interleukin-31-induced scratching depicts blockade of human interleukin-31 receptor A by a humanized monoclonal antibody.
Oyama S; Kitamura H; Kuramochi T; Higuchi Y; Matsushita H; Suzuki T; Goto M; Adachi H; Kasutani K; Sakamoto A; Iwayanagi Y; Kaneko A; Nanami M; Fujii E; Esaki K; Takashima Y; Shimaoka S; Hattori K; Kawabe Y
Exp Dermatol; 2018 Jan; 27(1):14-21. PubMed ID: 27714851
[TBL] [Abstract][Full Text] [Related]
34. Humanized anti-Lewis Y antibodies: in vitro properties and pharmacokinetics in rhesus monkeys.
Co MS; Baker J; Bednarik K; Janzek E; Neruda W; Mayer P; Plot R; Stumper B; Vasquez M; Queen C; Loibner H
Cancer Res; 1996 Mar; 56(5):1118-25. PubMed ID: 8640770
[TBL] [Abstract][Full Text] [Related]
35. Humanized antibodies against the alpha-chain of the IL-2 receptor and against the beta-chain shared by the IL-2 and IL-15 receptors in a monkey uveitis model of autoimmune diseases.
Guex-Crosier Y; Raber J; Chan CC; Kriete MS; Benichou J; Pilson RS; Kerwin JA; Waldmann TA; Hakimi J; Roberge FG
J Immunol; 1997 Jan; 158(1):452-8. PubMed ID: 8977222
[TBL] [Abstract][Full Text] [Related]
36. CD3 polymorphism in cynomolgus monkeys (Macaca fascicularis).
Uda A; Tanabayashi K; Mukai R; Yachi M; Nam KH; Yamada A
J Med Primatol; 2001 Jun; 30(3):141-7. PubMed ID: 11515669
[TBL] [Abstract][Full Text] [Related]
37. Quantitative determination of humanized monoclonal antibody rhuMAb2H7 in cynomolgus monkey serum using a Generic Immunoglobulin Pharmacokinetic (GRIP) assay.
Yang J; Ng C; Lowman H; Chestnut R; Schofield C; Sandlund B; Ernst J; Bennett G; Quarmby V
J Immunol Methods; 2008 Jun; 335(1-2):8-20. PubMed ID: 18402977
[TBL] [Abstract][Full Text] [Related]
38. Binding of cynomolgus monkey IgE to a humanized anti-human IgE antibody and human high affinity IgE receptor.
Meng YG; Singh N; Wong WL
Mol Immunol; 1996; 33(7-8):635-42. PubMed ID: 8760275
[TBL] [Abstract][Full Text] [Related]
39. Effect of anti-CD20 monoclonal antibody, Rituxan, on cynomolgus monkey and human B cells in a whole blood matrix.
Vugmeyster Y; Howell K; Bakshl A; Flores C; Canova-Davis E
Cytometry A; 2003 Apr; 52(2):101-9. PubMed ID: 12655653
[TBL] [Abstract][Full Text] [Related]
40. Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production.
Hashizume M; Uchiyama Y; Horai N; Tomosugi N; Mihara M
Rheumatol Int; 2010 May; 30(7):917-23. PubMed ID: 19639319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
